Welltower combines dominant senior-housing scale and accelerating FFO with powerful demographics, but its near-39x forward FFO valuation leaves limited margin for error.
Overview
Welltower is the world’s largest publicly traded healthcare REIT, owning, managing, or developing more than 2,500 communities across the United States, United Kingdom, and Canada. Its principal exposure is private-pay seniors housing, complemented by outpatient medical offices and contractual healthcare leases. The combination of regional density, premium properties, aligned RIDEA operators, and the data-driven Welltower Business System gives the company a stronger operating platform than fragmented competitors. **Q2 2026 demonstrated exceptional momentum:** revenue rose 39.1% year over year to $3.54 billion, normalized FFO per share increased 25.0% to $1.60, and total same-store NOI grew 15.5%, including 20.5% organic SHO SSNOI growth. Management raised full-year normalized FFO guidance to $6.36–$6.44 per share and increased the quarterly dividend 15% to $0.85. The central investment tension is valuation: at a starting price of $252.07, Welltower trades near 39x forward normalized FFO, so even 10% FFO growth produces only a 2.07% annualized five-year return if the multiple normalizes to 25x. Near-term catalysts include occupancy gains from 87%, supply constraints, continued capital recycling, and positive analyst revisions, but governance concerns and execution risk temper the otherwise strong long-term thesis.